Assessment and use of drug information references in Utah pharmacies
Objective: To determine which drug references Utah pharmacists use most frequently. To determine which types of drug information questions are most commonly asked, and whether Utah pharmacists have access to adequate references to respond to these questions.
Methods: A 19-question survey was created using Qualtrics, LLC (Provo, Utah) software. An electronic survey link was sent to 1,431 pharmacists with a valid e-mail address listed in the Department of Professional Licensing database. Questions focused on available references in the participant’s pharmacy, how current the references are, and the participant’s use of the references. Surveys were analyzed for participants practicing in either community or hospital pharmacies in the state of Utah.
Results: A total of 147 responses were included in the analysis. Approximately 44% of respondents practiced in the community, and 56% practiced in a hospital setting. The most commonly used references by Utah pharmacists are Micromedex, Lexicomp, UpToDate, Clinical Pharmacology, and Drug Facts & Comparisons. Pharmacists in the community frequently receive questions related to adverse drug reactions, drug interactions, and over-the-counter medications. Pharmacists in the hospital frequently receive questions relating to dosage and administration, drug interactions, and adverse drug reactions. About 89% of community pharmacists and 96% of hospital pharmacists feel available references are adequate to answer the questions they receive.
Conclusions: Utah pharmacists generally use large reference suites to answer drug information questions. The majority of pharmacists consider the references available to them to be adequate to answer the questions they receive.
2. Hassali MA, Khan TM, Shafie AA. Use of drug information resources by the community pharmacist in Penang, Malaysia. Inform Prim Care. 2010;18(3):213-216.
3. Zeolla MM, Cerulli J. Use of and familiarity with dietary supplement information references by practicing pharmacists. J Am Pharm Assoc (2003). 2008;48(3):401-404. doi: 10.1331/JAPhA.2008.07023
4. Rae CE, Rappaport HM, Mahajan P. Drug information sources used by community pharmacists in Louisiana: a preliminary study. J Pharm Technol. 1992;8(1):30-33.
5. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: Prescribing and transcribing-2007. Am J Health Syst Pharm. 2008;65(9):827-843. doi: 10.2146/ajhp080029
6. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: Prescribing and transcribing-2013. Am J Health Syst Pharm. 2014;71(11):924-942. doi: 10.2146/ajhp140032
7. Watt JW. Community pharmacist - recipient and source of drug information. Drug Inf J. 1977;11(4):209-212.
8. Kaiser Family Foundation. Total number of retail prescription drugs filled at pharmacies. http://kff.org/other/state-indicator/total-retail-rx-drugs/ (accessed July 13, 2016).
9. Malone P, Kier, KL, Stanovich, JE, eds. Drug information: A guide for pharmacists. New York: McGraw-Hill Medical; 2012: 60-62.
10. Cardoni AA, Palmer HA, Grover R. Drug information and the community pharmacist. J Am Pharm Assoc. 1977;17(11):680-684.
11. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-199.
12. Johnson TP, Wislar JS. Response rates and nonresponse errors in surveys. JAMA. 2012;307(17):1805-1806. doi: 10.1001/jama.2012.3532
13. Dunn OJ. Multiple comparisons using rank sums. Technometrics. 1964;6(3):241-252.
14. Siegel S, Castellan, NJ. Nonparametric statistics for the behavioral sciences. New York: McGraw Hill; 1988.
15. Giraudoux P (2015). pgirmess: Data Analysis in Ecology. R package version 1.6.2. http://CRAN.R-project.org/package=pgirmess (accessed July 13, 2016).
16. United States Census Bureau. Urban and rural classification. https://www.census.gov/geo/reference/urban-rural.html (accessed May 31, 2016).
The authors hereby transfer, assign, or otherwise convey to Pharmacy Practice: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print pr epublish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to Pharmacy Practice with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.